Interleukin-12 Antagonist [EPC]

103830 reported adverse events

Drugs of this class: USTEKINUMAB-TTWE USTEKINUMAB USTEKINUMAB-AAUZ USTEKINUMAB-AEKN USTEKINUMAB-AUUB USTEKINUMAB-HMNY USTEKINUMAB-STBA

These side effects are most commonly reported by patients taking drugs of the Interleukin-12 Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 14981
1 OFF LABEL USE 12939
2 PRODUCT DOSE OMISSION ISSUE 10264
3 FATIGUE 6995
4 PSORIASIS 6636
5 PAIN 6337
6 CROHN^S DISEASE 6081
7 ARTHRALGIA 5921
8 RASH 5725
9 PRODUCT USE ISSUE 5476
See all common reactions for Interleukin-12 Antagonist [EPC]

Drugs of the Interleukin-12 Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SWOLLEN JOINT COUNT INCREASED 1922 0.6021
1 RHEUMATIC FEVER 2543 0.5699
2 LUPUS VULGARIS 682 0.5413
3 DEEP VEIN THROMBOSIS POSTOPERATIVE 1066 0.5322
4 C-REACTIVE PROTEIN 492 0.5307
5 RHEUMATOID FACTOR POSITIVE 2982 0.5157
6 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3625 0.5054
7 FACET JOINT SYNDROME 1431 0.4391
8 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 883 0.4257
9 DUODENAL ULCER PERFORATION 3156 0.4240
See all enriched reactions for Interleukin-12 Antagonist [EPC]